Oyebimpe Adesina

Title(s)Assistant Professor, MED: Int Med Hematology/Oncology
SchoolSchool of Medicine
ORCID ORCID Icon0000-0002-3082-9114 Additional info
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Determination of bone blood flow and metabolism in adults with sickle cell disease using 18F-fluoride Total Body PET/CT
    UC Davis Department of Radiology EXPLORER Pilot AwardMay 6, 2022 - May 4, 2025
    Role: Principal Investigator
    A feasibility study of alendronate therapy for osteonecrosis of the femoral head in adults with sickle cell disease
    NIH K23HL148310Sep 20, 2021 - Aug 31, 2026
    Role: Principal Investigator
    Association between vertebral compression fractures, bone blood flow, and pain in adults with sickle cell disease
    Doris Duke Charitable Foundation/Clinical Scientist Development Award 2020095Jan 1, 2021 - Dec 31, 2024
    Role: Principal Investigator
    Evaluation of ovarian reserve, aging and fertility preservation in women with sickle cell disease
    NIH R21HD103034Jul 15, 2020 - Jun 30, 2022
    Role: Co-Investigator
    Spectrum Stanford Center for clinical and Translational Research and Education
    NIH KL2TR001083Sep 26, 2013 - Jun 30, 2019
    Role: Mentee
    PRIDE-Functional and Translational Genomics of Blood Disorders
    NIH R25HL106365Sep 20, 2010 - Jan 31, 2024
    Role: Mentee
    Career Development in Clinical Hematology
    NIH K12HL087165Sep 28, 2006 - May 31, 2018
    Role: Mentee

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Should we use bisphosphonates to treat bone complications in sickle cell disease? Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):623-626. Gollamudi J, Adesina O. PMID: 39644017.
      View in: PubMed   Mentions:
    2. Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis. Osteoporos Int. 2024 Oct 22. Adesina OO, Jenkins IC, Galvão F, de Moura AC, Fertrin KY, Zemel BS, Saad STO. PMID: 39433652.
      View in: PubMed   Mentions:    Fields:    
    3. Rates of Strokes in Californians with Sickle Cell Disease in the Post-STOP Era. Blood. 2024 Sep 20. Oluwole OB, Brunson A, Adesina OO, Willen S, Keegan TH, Fertrin KY, Wun T. PMID: 39302175.
      View in: PubMed   Mentions:    Fields:    
    4. Postpartum fevers, a rare presentation of secondary hemophagocytic lymphohistiocytosis. Clin Case Rep. 2023 Mar; 11(3):e7070. Lee J, Pham B, Karanjawala ZE, Adesina O. PMID: 36941837; PMCID: PMC10023518.
      View in: PubMed   Mentions: 2  
    5. Pregnancy outcomes in women with sickle cell disease in California. Am J Hematol. 2023 03; 98(3):440-448. Adesina OO, Brunson A, Fisch SC, Yu B, Mahajan A, Willen SM, Keegan THM, Wun T. PMID: 36594168; PMCID: PMC9942937.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    6. Clinical Vignettes, Part II: Eyes, Teeth, and Bone. Hematol Oncol Clin North Am. 2022 12; 36(6):1201-1215. Scott AW, Reilly GR, Laurence B, Adesina OO. PMID: 36400539; PMCID: PMC10204321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 2022 01 11; 6(1):307-320. Mahajan A, Brunson A, Adesina O, Keegan THM, Wun T. PMID: 34649273; PMCID: PMC8753193.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    8. Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management. Hematology Am Soc Hematol Educ Program. 2019 12 06; 2019(1):351-358. Adesina OO, Neumayr LD. PMID: 31808856; PMCID: PMC6913430.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    9. Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease. Blood Cells Mol Dis. 2020 02; 80:102369. Adesina OO, Jenkins IC, Wu QV, Fung EB, Narla RR, Lipkin EW, Mahajan K, Konkle BA, Kruse-Jarres R. PMID: 31677454; PMCID: PMC10185370.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Acute Care Utilization at End of Life in Sickle Cell Disease: Highlighting the Need for a Palliative Approach. J Palliat Med. 2020 01; 23(1):24-32. Johnston EE, Adesina OO, Alvarez E, Amato H, Paulukonis S, Nichols A, Chamberlain LJ, Bhatia S. PMID: 31390292.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    11. Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results. Blood Adv. 2019 05 14; 3(9):1476-1488. Adesina OO, Gurney JG, Kang G, Villavicencio M, Hodges JR, Chemaitilly W, Kaste SC, Zemel BS, Hankins JS. PMID: 31072833; PMCID: PMC6517655.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. Pediatr Blood Cancer. 2018 09; 65(9):e27228. Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, Brandow AM, Lebensburger JD, Adesina O, Chou ST, Zemel BS, Smeltzer MP, Wang WC, Gurney JG. PMID: 29797644.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    13. Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California. Blood Adv. 2017 Jul 11; 1(16):1287-1295. Adesina O, Brunson A, Keegan THM, Wun T. PMID: 29296770; PMCID: PMC5728545.
      View in: PubMed   Mentions: 37     Fields:    
    Oyebimpe's Networks
    Concepts (63)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California